Eleven Biotherapeutics Inc. said it regained compliance with Nasdaq Stock Market LLC's $1 minimum bid price listing requirement.

The Cambridge, Mass.-based company received a noncompliance notice from the Nasdaq in December 2017 as the closing bid price of the company's common stock was below $1 per share for 30 consecutive business days.

Nasdaq confirmed that the company regained compliance after the closing bid price for its common stock had been at $1 per share or greater for a minimum of 10 consecutive business days.